The immune-suppressive effects of pain.
Page
Gayle G
GG
Johns Hopkins University School of Nursing, Baltimore, Maryland, USA.
D000701:Analgesics, Opioid / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D000818:Animals; D002045:Bupivacaine / Q000494:pharmacology / Q000627:therapeutic use; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D005283:Fentanyl / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007108:Immune Tolerance / Q000502:physiology*; D007153:Immunologic Deficiency Syndromes / Q000209:etiology; D007213:Indomethacin / Q000494:pharmacology / Q000627:therapeutic use; D007378:Interleukins / Q000502:physiology; D007813:Laparotomy; D051379:Mice; D008959:Models, Neurological; D009020:Morphine / Q000494:pharmacology / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D009368:Neoplasm Transplantation; D015213:Neuroimmunomodulation / Q000187:drug effects / Q000502:physiology*; D010146:Pain / Q000150:complications / Q000276:immunology* / Q000503:physiopathology; D011183:Postoperative Complications / Q000276:immunology; D051381:Rats; D011916:Rats, Inbred F344; D013315:Stress, Psychological / Q000150:complications / Q000276:immunology
D000701:Analgesics, Opioid; D016861:Cyclooxygenase Inhibitors; D007378:Interleukins; D009020:Morphine; D005283:Fentanyl; D007213:Indomethacin; D002045:Bupivacaine